American BriVision (ABVC) Improves Working Capital and Reduce Debt.
American BriVision Announces Two Financial Transactions to Improve Working Capital and Reduce Debt
FREMONT, CA, April 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – American...
FDA Authorizes Athersys (ATHX) to Initiate a Pivotal Clinical Trial!
FDA Authorizes Athersys to Initiate a Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome.
(Editors note: a...
Exosomes, Extracellular Vesicles, and the CoronaVirus.
Uploading a Series of Articles on Extracellular Vesicles, Including Potential Effects on the CoronaVirus and ARDS.
Article #1: the basics in non-scientific terms from Larry...
Adding Corbis Pharma (CRBP) $5.55 to Watch List.
Running Clinical Trials Full Steam With $46 Million Banked in Late February.
Not thinly, but lightly traded. Ready, locked and loaded.
All of the common...
Boo Ya. Brokerage Sets $12 Price Target for Athersys (ATHX) $2.96.
A major Wall Street firm that specializes in Bio and Medtech Companies has a $12 price target out on Athersys from one of its...
Adding American BriVision (ABVC) $2.00 to Watch List.
New client and an incubator, studying now. Thinly, thinly traded. We like what we've read so far about their vitreous substitute (eyeball fluid) called...
Immunomedics (IMMU) up 100% Today or $2 Billion in Value & Stand Down VIII:
Bear Comments from Roubini, Jim Chanos, Jim Rogers and James A. Kostohryz
Don't Be That Guy in Denial!
Just like people who are in denial and don't...
Citius (CTXR) and Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
- Novellus's patented mRNA-based cell-reprogramming...
New Report: Citius (CTXR) Trades 13 Million Shares on CoronaVirus and Candida Auris News.
Announces Mino-lok® Erdicates the Deadly and Untreatable C. Auris Bacteria.Announces License of Treatment for CoronaVirus Respiratory Failure.
Read In Between the Lines. If the Mino-Lok®...
OMNIQ (OMQS) Corp. Acquires Eyepax Parking Assets.
OMNIQ Corp. Acquires Eyepax USA's Intellectual Property and Technology to Establish Leadership in Multibillion Dollar Automated Parking Solutions Market
OMNIQ is now positioned as a...
Latest article
Jeffrey Gundlach: Reckoning is Coming.
Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm.
On 11 November 2020, Gundlach remarked in an interview with...
Who’s the Next Eric Sprott?
Eric Sprott, on Who is the Next Eric Sprott!
To say Eric Sprott has left a legendary mark on the world of mining investment would...
Perpetua (PPTA) Raises $300 Million.
Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...
